SLC2A1 and glucose metabolism disease: First, by assessing GLUT expression across glucose-metabolizing tissues, we identified the gastrocnemius muscle as GEN’s primary target for ameliorating glucose metabolic disorders in ovariectomized mice, showing significantly greater regulatory efficacy than the tibialis anterior muscle and liver tissue.